Trelleborg expands medical testing capability in US

Tustin, California – Trelleborg Medical Solutions (TMS) has opened a new laboratory in Tustin to support the development of sustained-release and drug-elution technologies.

The new lab is part of Trelleborg’s goal to become a “total solution provider” for pharmaceutical original equipment manufacturers, said the Swedish group 1 Aug.

The unit is equipped to support customers that need to transfer an existing test method or develop a new one, explained Don Bonitati, TMS Americas segment director.

According to Bonitati, not every pharmaceutical company has the capacity or experience to perform its own product-release testing.

“We’ve established methods that fit a product's specific characteristics, ensuring accurate and reliable results while maintaining cost-effectiveness,” he added.

The analytical team can provide help in a range of areas such as early-stage development, clinical production, manufacturable scalability or market product support.

Other areas of support include study design, method development and execution of tests to achieve meaningful data to advance implantable drug delivery systems and combination devices.

The lab experts also carry out material characterisation and analyse active pharmaceutical ingredients, according to the Trelleborg release.